Parse Biosciences. a Seattle biotech startup developing single cell sequencing products used by more than 1,000 labs worldwide, raised $50 million as part of a Series C equity round and a debt facility.
Parse Biosciences. a Seattle biotech startup developing single cell sequencing products used by more than 1,000 labs worldwide, raised $50 million as part of a Series C equity round and a debt facility.